Biora Therapeutics Net Income
| BIOR Stock | USD 0.22 0.00 0.00% |
Biora Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate data for zero technical drivers for Biora Therapeutics, which can be compared to its peers.
Biora Therapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Biora Therapeutics' valuation are provided below:Biora Therapeutics does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Biora |
Biora Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biora Therapeutics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biora Therapeutics.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Biora Therapeutics on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Biora Therapeutics or generate 0.0% return on investment in Biora Therapeutics over 90 days. Biora Therapeutics is related to or competes with Chia Tai, Orgenesis, International Stem, and Epigenomics. Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics More
Biora Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biora Therapeutics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biora Therapeutics upside and downside potential and time the market with a certain degree of confidence.
Biora Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biora Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biora Therapeutics' standard deviation. In reality, there are many statistical measures that can use Biora Therapeutics historical prices to predict the future Biora Therapeutics' volatility.Biora Therapeutics Backtested Returns
We have found three technical indicators for Biora Therapeutics, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Biora Therapeutics are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Biora Therapeutics has perfect predictability. Overlapping area represents the amount of predictability between Biora Therapeutics time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biora Therapeutics price movement. The serial correlation of 1.0 indicates that 100.0% of current Biora Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Biora Therapeutics reported net income of (124.11 Million). This is 136.37% lower than that of the Biotechnology sector and 277.19% lower than that of the Health Care industry. The net income for all United States stocks is 121.74% higher than that of the company.
Biora Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biora Therapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Biora Therapeutics could also be used in its relative valuation, which is a method of valuing Biora Therapeutics by comparing valuation metrics of similar companies.Biora Therapeutics is currently under evaluation in net income category among its peers.
Biora Fundamentals
| Return On Asset | -1.25 | |||
| Current Valuation | 38.44 M | |||
| Shares Outstanding | 4.52 M | |||
| Shares Owned By Insiders | 0.10 % | |||
| Shares Owned By Institutions | 36.00 % | |||
| Number Of Shares Shorted | 258.12 K | |||
| Price To Sales | 1.49 X | |||
| Revenue | 4 K | |||
| Gross Profit | 1.25 M | |||
| EBITDA | (114.05 M) | |||
| Net Income | (124.11 M) | |||
| Cash And Equivalents | 37.06 M | |||
| Cash Per Share | 0.19 X | |||
| Total Debt | 47.43 M | |||
| Current Ratio | 1.69 X | |||
| Book Value Per Share | (36.43) X | |||
| Cash Flow From Operations | (48.5 M) | |||
| Short Ratio | 2.37 X | |||
| Earnings Per Share | 0.36 X | |||
| Target Price | 34.0 | |||
| Number Of Employees | 58 | |||
| Beta | 1.28 | |||
| Market Capitalization | 1.86 M | |||
| Total Asset | 31.21 M | |||
| Retained Earnings | (950.96 M) | |||
| Working Capital | (43.9 M) | |||
| Current Asset | 667 K | |||
| Current Liabilities | 3.01 M | |||
| Net Asset | 31.21 M |
About Biora Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biora Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biora Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biora Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Biora Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biora Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biora Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Biora OTC Stock
The ability to find closely correlated positions to Biora Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biora Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biora Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biora Therapeutics to buy it.
The correlation of Biora Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biora Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biora Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biora Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Biora OTC Stock Analysis
When running Biora Therapeutics' price analysis, check to measure Biora Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biora Therapeutics is operating at the current time. Most of Biora Therapeutics' value examination focuses on studying past and present price action to predict the probability of Biora Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biora Therapeutics' price. Additionally, you may evaluate how the addition of Biora Therapeutics to your portfolios can decrease your overall portfolio volatility.